Elevated C-reactive peptide (CRP, an inflammatory marker) observed in women with PCOS led to the “chronic inflammation hypothesis.” However, systemic inflammatory markers that would support this hypothesis of low-grade chronic inflammation are not generally elevated in women with PCOS. This evidence concerns the gene CRP and polycystic ovary syndrome.